comparemela.com

Latest Breaking News On - David adlington - Page 1 : comparemela.com

CARL ZEISS MEDITEC AG : JP Morgan gives a Sell rating

David Adlington from JP Morgan retains his negative opinion on the stock with a Sell rating. The target price is unchanged at EUR 68.

Carl Zeiss Meditec just above annual low - JPMorgan skeptical

Despite a very skeptical analyst commentary, Carl Zeiss Meditec shares did not initially mark another low for the year on Friday morning. Although the Jena-based company s shares fell by 2.2 percent.

GERRESHEIMER AG : JP Morgan reiterates its Buy rating

In a research note published by David Adlington, JP Morgan advises its customers to buy the stock. The target price continues to be set at EUR 125.70.

JPMorgan rates Gerresheimer at Overweight - Target 125 70 euros

The US bank JPMorgan has left its rating for Gerresheimer at Overweight with a target price of 125.70 euros. The takeover of Bormioli initially brings a decent profit contribution at a time when some.

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan remains a Sell rating
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.